Breast Cancer Trial, Recruiting (NCT07300995)

Breast Cancer Trial, Recruiting NCT07300995 Sponsor: Duke University Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07300995 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are currently receiving cancer care at a Duke Cancer Network (DCN) clinic
People who have been diagnosed with breast cancer at any stage (Stage I through Stage IV)
People who have experienced pain on at least 10 days in the past month, with a worst pain rating of 4 or higher on a scale of 0 to 10 in the past week
People who are biologically female
People who are 55 years old or older
People who are able to speak and read English
People who have sufficient hearing and vision to take part in video calls and phone sessions

Who may not be able to join:

People who have taken part in a pain coping skills training program within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 919-416-3408

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07300995

Sponsor: Duke University

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 919-416-3408

More information: https://clinicaltrials.gov/study/NCT07300995

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are currently receiving cancer care at a Duke Cancer Network (DCN) clinic
People who have been diagnosed with breast cancer at any stage (Stage I through Stage IV)
People who have experienced pain on at least 10 days in the past month, with a worst pain rating of 4 or higher on a scale of 0 to 10 in the past week
People who are biologically female
People who are 55 years old or older
People who are able to speak and read English
People who have sufficient hearing and vision to take part in video calls and phone sessions

Who may not be able to join:

People who have taken part in a pain coping skills training program within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Duke University

Registry

ClinicalTrials.gov

Start date

30 June 2026

Est. completion

30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain severity as measured by the Brief Pain Inventory (BPI); Pain interference as measured by the Brief Pain Inventory (BPI); Health Related Quality of Life (HR-QOL) as measured by the Patient Reported Outcomes Measurement Information System (PROMIS-29) - Physical Function; Health Related Quality of Life (HR-QOL) as measured by the Patient Reported Outcomes Measurement Information System (PROMIS-29) - Mental Health

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov